Regeneron Announces Presentation at the 35th Annual J.P. Morgan Healthcare Conference

TARRYTOWN, N.Y.,Dec. 22, 2016/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast its presentation at the 35thAnnual J.P. Morgan Healthcare Conference onMonday, January 9, 2017.  The presentation is scheduled for3:30 p.m. Pacific Time(6:30 p.m. Eastern Time) and may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page.  A breakout session will immediately follow the formal presentation and can also be accessed atwww.regeneron.com.  An archived version of the presentation and the breakout session will be available for 30 days.

Regeneron (NASDAQ:REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visitwww.regeneron.comor follow@Regeneronon Twitter.